Volume | 32,025 |
|
|||||
News | - | ||||||
Day High | 40.50 | Low High |
|||||
Day Low | 40.17 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
SPDR S&P Pharmaceuticals | XPH | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
40.50 | 40.17 | 40.50 | 40.22 | 40.39 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
196 | 32,025 | 40.43 | 1,294,747 | - | 34.6704 - 45.62 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
20:00:00 | 100 | 40.22 | USD |
SPDR S&P Pharmaceuticals Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
217.19M | 5.40M | - | 3.54M | -5.01M | -0.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News SPDR S&P Pharmaceuticals
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
XPH Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 41.27 | 41.51 | 40.17 | 41.07 | 24,666 | -1.05 | -2.54% |
1 Month | 39.06 | 41.70 | 39.06 | 40.91 | 26,879 | 1.16 | 2.97% |
3 Months | 44.60 | 44.71 | 38.88 | 41.65 | 34,107 | -4.38 | -9.82% |
6 Months | 36.84 | 45.62 | 36.49 | 41.40 | 45,263 | 3.38 | 9.17% |
1 Year | 40.61 | 45.62 | 34.6704 | 40.85 | 42,511 | -0.39 | -0.96% |
3 Years | 50.52 | 53.82 | 34.6704 | 43.68 | 55,649 | -10.30 | -20.39% |
5 Years | 38.76 | 56.32 | 30.30 | 43.22 | 66,556 | 1.46 | 3.77% |
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). |